Elevance Health, Inc.
ELVAPI behind this page
ELV FY 2025 request
Playground key active
/api/financials?ticker=ELV&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Premiums Earned Net | 164,639 | 144,166 | +14.2% |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 6,315 | 2,630 | +140.1% |
| Health Benefits · Operating Segments | 159,458 | 142,668 | +11.8% |
| Total · Operating Segments | 6,315 | 2,630 | +140.1% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -1,134 | -1,132 | -0.2% |
| Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 24,470 | 22,630 | +8.1% |
| Product · CarelonRx | 24,470 | 22,630 | +8.1% |
| Product · Total | 24,470 | 22,630 | +8.1% |
| Service fees | 8,475 | 8,408 | +0.8% |
| Service fees · Carelon Services | 826 | 790 | +4.6% |
| Service fees · CarelonRx | 13 | 5 | +160.0% |
| Service fees · Health Benefits | 7,636 | 7,607 | +0.4% |
| Service fees · Total | 839 | 795 | +5.5% |
| Operating Revenue | 197,584 | 175,204 | +12.8% |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 21,175 | 14,541 | +45.6% |
| Carelon Services · Operating Segments | 7,141 | 3,420 | +108.8% |
| Carelon Services · Operating Segments | 28,316 | 17,961 | +57.7% |
| CarelonRx · Operating Segments | 18,917 | 13,326 | +42.0% |
| CarelonRx · Operating Segments | 24,483 | 22,635 | +8.2% |
| CarelonRx · Operating Segments | 43,400 | 35,961 | +20.7% |
| Corporate And Other · Operating Segments | 463 | 303 | +52.8% |
| Corporate And Other · Operating Segments | 463 | 309 | +49.8% |
| Health Benefits · Operating Segments | 167,094 | 150,275 | +11.2% |
| Health Benefits · Operating Segments | 167,094 | 150,275 | +11.2% |
| Reportable Segments | 197,584 | 175,204 | +12.8% |
| Total · Operating Segments | 40,092 | 27,867 | +43.9% |
| Total · Operating Segments | 31,624 | 26,055 | +21.4% |
| Total · Operating Segments | 71,716 | 53,922 | +33.0% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -41,689 | -29,302 | -42.3% |
| Intersegment Elimination · Operating revenue - affiliated | -40,555 | -28,170 | -44.0% |
| Intersegment Elimination · Operating revenue - unaffiliated | -1,134 | -1,132 | -0.2% |
Show Major Customers breakouts |
|||
| Operating revenue - unaffiliated | 197,584 | 175,204 | +12.8% |
| Net Investment Income | 2,194 | 2,051 | +7.0% |
Show Business Segments breakouts |
|||
| Reportable Segments | 2,194 | 2,051 | +7.0% |
Show Legal Entity breakouts |
|||
| Mosaic Health · Line Of Credit | 18 | 7 | +157.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 45 | 110 | -59.1% |
| Net Losses Gains On Financial Instruments | -653 | -445 | -46.7% |
Show Business Segments breakouts |
|||
| Reportable Segments | -653 | -445 | -46.7% |
| Revenue | 199,125 | 177,011 | +12.5% |
Show Business Segments breakouts |
|||
| Reportable Segments | 199,125 | 177,011 | +12.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -44 | 96 | -145.8% |
| Policyholder Benefits And Claims Incurred Net | 148,223 | 127,567 | +16.2% |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 24,283 | 14,388 | +68.8% |
| Corporate And Other · Operating Segments | 25 | 19 | +31.6% |
| Health Benefits · Operating Segments | 143,889 | 126,703 | +13.6% |
| Total · Operating Segments | 24,283 | 14,388 | +68.8% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -19,974 | -13,543 | -47.5% |
| Cost of Revenue | 21,178 | 19,750 | +7.2% |
Show Business Segments breakouts |
|||
| CarelonRx · Operating Segments | 40,077 | 32,978 | +21.5% |
| Total · Operating Segments | 40,077 | 32,978 | +21.5% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -18,899 | -13,228 | -42.9% |
| Selling, General & Administrative | 20,984 | 20,025 | +4.8% |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 3,073 | 2,856 | +7.6% |
| CarelonRx · Operating Segments | 905 | 811 | +11.6% |
| Corporate And Other · Operating Segments | 775 | 1,560 | -50.3% |
| Health Benefits · Operating Segments | 19,047 | 17,329 | +9.9% |
| Total · Operating Segments | 3,978 | 3,667 | +8.5% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -2,816 | -2,531 | -11.3% |
Show Related Party Transactions By Related Party breakouts |
|||
| Liberty Dental | 583 | 519 | +12.3% |
| Mosaic Health | 732 | — | — |
| Interest Expense | 1,402 | 1,185 | +18.3% |
Show Business Segments breakouts |
|||
| Reportable Segments | 1,402 | 1,185 | +18.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,391 | 1,172 | +18.7% |
| Amortization Of Intangible Assets | 628 | 580 | +8.3% |
Show Business Segments breakouts |
|||
| Reportable Segments | 628 | 580 | +8.3% |
| Benefits Losses And Expenses | 192,415 | 169,107 | +13.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,718 | 1,451 | +18.4% |
| Income Before Taxes | 6,710 | 7,904 | -15.1% |
Show Business Segments breakouts |
|||
| Reportable Segments | 6,710 | 7,904 | -15.1% |
| Income Tax Expense (Benefit) | 1,049 | 1,933 | -45.7% |
| Net Income | 5,661 | 5,971 | -5.2% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -1 | -9 | +88.9% |
| Retained Earnings | 5,662 | 5,980 | -5.3% |
| Net Income Loss Attributable To Noncontrolling Interest | 1 | 9 | -88.9% |
| Net Income | 5,662 | 5,980 | -5.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5,662 | 5,980 | -5.3% |
| EPS (Basic) | 25.28 | 25.81 | -2.1% |
| EPS (Diluted) | 25.21 | 25.68 | -1.8% |
| General & Administrative (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 327 | 279 | +17.2% |
| Operating Income | 7,199 | 7,862 | -8.4% |
Show Business Segments breakouts |
|||
| Carelon Services · Operating Segments | 960 | 717 | +33.9% |
| CarelonRx · Operating Segments | 2,418 | 2,172 | +11.3% |
| Corporate And Other · Operating Segments | -337 | -1,270 | +73.5% |
| Health Benefits · Operating Segments | 4,158 | 6,243 | -33.4% |
| Reportable Segments | 7,199 | 7,862 | -8.4% |
| Total · Operating Segments | 3,378 | 2,889 | +16.9% |
| Comprehensive Income | 6,358 | 6,146 | +3.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 6,358 | 6,146 | +3.4% |
| Other Comprehensive Income (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 696 | 166 | +319.3% |
| Wtd Avg Shares (Basic) | 224 | 231.7 | -3.3% |
| Wtd Avg Shares (Diluted) | 224.6 | 232.9 | -3.6% |
| Marketing And Advertising Expense | 395 | 540 | -26.9% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 6,710 | 7,904 | -15.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -1,762 | -1,355 | -30.0% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 144,276 | 123,639 | +16.7% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 9,491 | 8,288 | +14.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,548 | 1,870 | +36.3% |
| Available For Sale Securities Debt Securities Current | 25,884 | 25,201 | +2.7% |
| Equity Securities Fv Ni | 740 | 1,192 | -37.9% |
Show Financial Instrument breakouts |
|||
| Common equity securities | 35 | 118 | -70.3% |
| Exchange Traded Funds | 650 | 1,002 | -35.1% |
| Private Equity Funds | 55 | 72 | -23.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 24 | 487 | -95.1% |
| Premiums Receivable At Carrying Value | 10,073 | 8,011 | +25.7% |
| Self Funded Receivables Net | 5,162 | 5,044 | +2.3% |
| Other Receivables | 6,307 | 6,016 | +4.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 99 | 49 | +102.0% |
| Parent Company · Subsidiaries | 208 | 4,697 | -95.6% |
| Other Assets Current | 5,344 | 4,700 | +13.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 683 | 705 | -3.1% |
| Total Current Assets | 63,001 | 58,942 | +6.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 3,562 | 7,808 | -54.4% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 4,679 | 4,652 | +0.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 151 | 159 | -5.0% |
| Goodwill | 28,344 | 28,277 | +0.2% |
Show Business Segments breakouts |
|||
| Carelon Services | 3,994 | 3,798 | +5.2% |
| CarelonRx | 1,898 | 1,915 | -0.9% |
| Health Benefits | 22,452 | 22,564 | -0.5% |
Show Business Acquisition breakouts |
|||
| Centers Plan for Healthy Living LLC | 202 | — | — |
| RSV QOZB LTSS, Inc | 1,827 | — | — |
| Series Of Individually Immaterial Business Acquisitions | 121 | 3,066 | -96.1% |
| Other Non-Current Assets | 2,310 | 2,140 | +7.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 689 | 584 | +18.0% |
| Total Assets | 121,494 | 116,889 | +3.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 79,953 | 75,360 | +6.1% |
| Operating Lease Right-of-Use Assets | 452 | 567 | -20.3% |
| Intangible Assets | 3,043 | 4,201 | -27.6% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Contractual Rights | 130 | 212 | -38.7% |
| Customer Relationships | 2,628 | 3,633 | -27.7% |
| Other Intangible Assets | 285 | 356 | -19.9% |
| Other Assets | |||
| Other Long Term Investments | 10,839 | 9,749 | +11.2% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Common equity securities | 6 | 18 | -66.7% |
| Fair Value Inputs Level3 · Estimate Of Fair Value Fair Value Disclosure | 762 | 610 | +24.9% |
Show Financial Instrument breakouts |
|||
| Common equity securities | 6 | 18 | -66.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 3,830 | 3,636 | +5.3% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 781 | 642 | +21.7% |
| Estimate Of Fair Value Fair Value Disclosure | 762 | 610 | +24.9% |
| Intangible Assets Net Excluding Goodwill | 11,200 | 12,094 | -7.4% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 17,084 | 15,746 | +8.5% |
| Other Policyholder Funds | 3,632 | 4,204 | -13.6% |
| Unearned Premiums | 1,493 | 1,508 | -1.0% |
| Accounts Payable And Accrued Liabilities Current | 7,322 | 6,927 | +5.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,292 | 737 | +75.3% |
| Short Term Borrowings | 150 | 365 | -58.9% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure | 150 | 365 | -58.9% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 150 | 365 | -58.9% |
| Estimate Of Fair Value Fair Value Disclosure | 150 | 365 | -58.9% |
| Current Portion of Long-Term Debt | 1,099 | 1,649 | -33.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,099 | 1,649 | -33.4% |
| Other Liabilities Current | 10,255 | 10,029 | +2.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company · Nonrelated Party | 687 | 610 | +12.6% |
| Total Current Liabilities | 41,035 | 40,581 | +1.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 3,078 | 2,996 | +2.7% |
| Non-Current Liabilities | |||
| Available For Sale Securities Debt Securities Noncurrent | 1,121 | 1,035 | +8.3% |
| Long-Term Debt | 30,797 | 29,218 | +5.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 30,772 | 29,193 | +5.4% |
| Deferred Tax Liabilities | 2,110 | 2,148 | -1.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 10 | 55 | -81.8% |
| Other Non-Current Liabilities | 3,381 | 3,326 | +1.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,211 | 1,801 | +22.8% |
| Total Liabilities | 77,468 | 75,463 | +2.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 36,071 | 34,045 | +6.0% |
| Long-Term Debt | 31,896 | 30,867 | +3.3% |
Show Debt Instrument breakouts |
|||
| 1.500%, due 2026 · Senior Unsecured Notes | 750 | 749 | +0.1% |
| 2.250%, due 2030 · Senior Unsecured Notes | 1,084 | 1,075 | +0.8% |
| 2.550%, due 2031 · Senior Unsecured Notes | 980 | 971 | +0.9% |
| 2.875%, due 2029 · Senior Unsecured Notes | 823 | 822 | +0.1% |
| 3.125%, due 2050 · Senior Unsecured Notes | 989 | 988 | +0.1% |
| 3.600%, due 2051 · Senior Unsecured Notes | 1,234 | 1,234 | 0.0% |
| 3.650%, due 2027 · Senior Unsecured Notes | 1,597 | 1,596 | +0.1% |
| 3.700%, due 2049 · Senior Unsecured Notes | 813 | 813 | 0.0% |
| 4.000% Senior Unsecured Notes Due 2028 · Senior Unsecured Notes | 747 | — | — |
| 4.100%, due 2032 · Senior Unsecured Notes | 596 | 596 | 0.0% |
| 4.101%, due 2028 · Senior Unsecured Notes | 1,244 | 1,238 | +0.5% |
| 4.375%, due 2047 · Senior Unsecured Notes | 1,389 | 1,389 | 0.0% |
| 4.500%, due 2026 · Senior Unsecured Notes | 349 | 349 | 0.0% |
| 4.550% due 2052 · Senior Unsecured Notes | 690 | 689 | +0.1% |
| 4.550%, due 2048 · Senior Unsecured Notes | 841 | 840 | +0.1% |
| 4.600% Senior Unsecured Notes Due 2032 · Senior Unsecured Notes | 742 | — | — |
| 4.625%, due 2042 · Senior Unsecured Notes | 861 | 860 | +0.1% |
| 4.650%, due 2043 · Senior Unsecured Notes | 975 | 975 | 0.0% |
| 4.650%, due 2044 · Senior Unsecured Notes | 768 | 768 | 0.0% |
| 4.750%, due 2030 · Senior Unsecured Notes | 751 | 731 | +2.7% |
| 4.750%, due 2033 · Senior Unsecured Notes | 1,005 | 973 | +3.3% |
| 4.850%, due 2054 · Senior Unsecured Notes | 247 | 247 | 0.0% |
| 4.950%, due 2031 · Senior Unsecured Notes | 751 | 726 | +3.4% |
| 5.000% Senior Unsecured Notes Due 2036 · Senior Unsecured Notes | 985 | — | — |
| 5.100%, due 2044 · Senior Unsecured Notes | 548 | 548 | 0.0% |
| 5.125%, due 2053 · Senior Unsecured Notes | 1,085 | 1,084 | +0.1% |
| 5.150%, due 2029 · Senior Unsecured Notes | 613 | 601 | +2.0% |
| 5.200%, due 2035 · Senior Unsecured Notes | 1,188 | 1,151 | +3.2% |
| 5.375%, due 2034 · Senior Unsecured Notes | 1,020 | 992 | +2.8% |
| 5.500%, due 2032 · Senior Unsecured Notes | 656 | 635 | +3.3% |
| 5.650%, due 2054 · Senior Unsecured Notes | 986 | 985 | +0.1% |
| 5.700% Senior Unsecured Notes Due 2055 B · Senior Unsecured Notes | 492 | — | — |
| 5.700%, due 2055 · Senior Unsecured Notes | 1,328 | 1,327 | +0.1% |
| 5.800%, due 2040 · Senior Unsecured Notes | 115 | 115 | 0.0% |
| 5.850% due 2064 · Senior Unsecured Notes | 790 | 789 | +0.1% |
| 5.850%, due 2036 · Senior Unsecured Notes | 397 | 397 | 0.0% |
| 5.950%, due 2034 · Senior Unsecured Notes | 335 | 335 | 0.0% |
| 6.100%, due 2052 · Senior Unsecured Notes | 742 | 742 | 0.0% |
| 6.375%, due 2037 · Senior Unsecured Notes | 365 | 364 | +0.3% |
| 9.000%, due 2027 · Surplus Notes | 25 | 25 | 0.0% |
| Operating Lease Liabilities | 529 | 658 | -19.6% |
| Other Liabilities | |||
| Liability For Future Policy Benefits | 145 | 190 | -23.7% |
| Stockholders' Equity | |||
| Common Stock | 2 | 2 | 0.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2 | 2 | 0.0% |
| Additional Paid-In Capital | 8,938 | 8,911 | +0.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 8,938 | 8,911 | +0.3% |
| Retained Earnings | 35,393 | 33,549 | +5.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 35,393 | 33,549 | +5.5% |
| Accumulated Other Comprehensive Income | -451 | -1,147 | +60.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -451 | -1,147 | +60.7% |
| Total Stockholders' Equity | 43,882 | 41,315 | +6.2% |
Show Legal Entity breakouts |
|||
| California Department of Managed Health Care Regulated Entities | 2,969 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 43,882 | 41,315 | +6.2% |
| Minority Interest | 144 | 111 | +29.7% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 44,026 | 41,426 | +6.3% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest | -332 | -399 | +16.8% |
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | -28 | -24 | -16.7% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | -199 | -207 | +3.9% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | 106 | -523 | +120.3% |
| Accumulated Other Comprehensive Income | -451 | -1,147 | +60.7% |
| Additional Paid In Capital | 8,938 | 8,911 | +0.3% |
| Aoci Including Portion Attributable To Noncontrolling Interest | -451 | -1,147 | +60.7% |
| Common Stock | 2 | 2 | 0.0% |
| Future policy benefits: | 5 | 8 | -37.5% |
| Non-credit components of impairments on investments: | -3 | -2 | -50.0% |
| Noncontrolling Interest | 144 | 111 | +29.7% |
| Retained Earnings | 35,393 | 33,549 | +5.5% |
| Total Liabilities & Equity | 121,494 | 116,889 | +3.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 79,953 | 75,360 | +6.1% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Income Loss From Equity Method Investments | -398 | -1 | -39700.0% |
| Depreciation Amortization And Accretion Net | 1,546 | 1,393 | +11.0% |
| Deferred Income Taxes | -279 | -374 | +25.4% |
| Asset Impairment Charges | 108 | 103 | +4.9% |
| Stock-Based Compensation | 276 | 191 | +44.5% |
Show Award Type breakouts |
|||
| Employee Stock | 11 | 10 | +10.0% |
| Increase Decrease In Receivables | -2,526 | -683 | -269.8% |
| Increase Decrease In Other Operating Assets | 57 | 824 | -93.1% |
| Increase Decrease In Insurance Liabilities | 228 | -1,840 | +112.4% |
| Increase Decrease In Deferred Revenue | -15 | -113 | +86.7% |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | -720 | -272 | -164.7% |
| Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | -297 | 404 | -173.5% |
| Increase Decrease In Other Operating Capital Net | -4 | 39 | -110.3% |
| Net Cash from Operations | 4,290 | 5,808 | -26.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,839 | 1,451 | +233.5% |
| Investing Activities | |||
| Payments To Acquire Investments | -15,026 | -17,986 | +16.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -296 | -3,240 | +90.9% |
| Proceedsfromsaleofequityandfixedmaturitysecurities | 13,324 | 16,547 | -19.5% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 1,771 | 2,025 | -12.5% |
| Increase Decrease In Collateral Held Under Securities Lending | -385 | 73 | -627.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 17 | -16 | +206.2% |
| Payments To Acquire Businesses Net Of Cash Acquired | 88 | -4,809 | +101.8% |
| Capital Expenditures | -1,116 | -1,256 | +11.1% |
| Net Cash from Investing | -1,344 | -5,167 | +74.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -1,309 | -2,049 | +36.1% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 2,991 | 7,710 | -61.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,991 | 7,710 | -61.2% |
| Repayments Of Long Term Debt | -2,147 | -1,650 | -30.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,147 | -1,650 | -30.1% |
| Proceeds From Short Term Debt | 1,505 | 275 | +447.3% |
| Repayments Of Short Term Debt | -1,720 | -135 | -1174.1% |
| Increase Decrease In Securities Lending Payable | 386 | -75 | +614.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -17 | 16 | -206.2% |
| Increase Decrease In Outstanding Checks Financing Activities | 1,312 | -638 | +305.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 500 | -717 | +169.7% |
| Share Repurchases | -2,605 | -2,900 | +10.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,605 | -2,900 | +10.2% |
| Payments Of Dividends | -1,529 | -1,508 | -1.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -1,611 | -1,586 | -1.6% |
| Proceeds From Stock Plans | 79 | 221 | -64.3% |
| Tax Withholding for Share Compensation | -32 | -109 | +70.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -32 | -109 | +70.6% |
| Proceeds From Payments For Other Financing Activities | 22 | 2 | +1000.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -10 | — | — |
| Net Cash from Financing | -1,738 | 1,193 | -245.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,852 | 985 | -389.5% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -5 | -6 | +16.7% |
| Net Change in Cash | 1,203 | 1,828 | -34.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 678 | 387 | +75.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9,491 | 8,288 | +14.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,548 | 1,870 | +36.3% |
Values in millions USD. Source: SEC EDGAR 10-K filing.